Screener
Vor Biopharma VOR Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $2.94M.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's total debt?
- Vor Biopharma (VOR) reported total debt of $2.94M in Q1 2026.
- How has Vor Biopharma's total debt changed year-over-year?
- Vor Biopharma's total debt decreased by 90.5% year-over-year, from $30.78M to $2.94M.
- What is the long-term trend for Vor Biopharma's total debt?
- Over 5 years (2020 to 2025), Vor Biopharma's total debt has grown at a -30.3% compound annual growth rate (CAGR), from $18.29M to $3M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Vor Biopharma's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude